Schnitker, F.; Liu, Y.; Keitsch, S.; Soddemann, M.; Verhasselt, H.L.; Kehrmann, J.; Grassmé, H.; Kamler, M.; Gulbins, E.; Wu, Y.
Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections. Int. J. Mol. Sci. 2023, 24, 14004.
https://doi.org/10.3390/ijms241814004
AMA Style
Schnitker F, Liu Y, Keitsch S, Soddemann M, Verhasselt HL, Kehrmann J, Grassmé H, Kamler M, Gulbins E, Wu Y.
Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections. International Journal of Molecular Sciences. 2023; 24(18):14004.
https://doi.org/10.3390/ijms241814004
Chicago/Turabian Style
Schnitker, Fabian, Yongjie Liu, Simone Keitsch, Matthias Soddemann, Hedda Luise Verhasselt, Jan Kehrmann, Heike Grassmé, Markus Kamler, Erich Gulbins, and Yuqing Wu.
2023. "Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections" International Journal of Molecular Sciences 24, no. 18: 14004.
https://doi.org/10.3390/ijms241814004
APA Style
Schnitker, F., Liu, Y., Keitsch, S., Soddemann, M., Verhasselt, H. L., Kehrmann, J., Grassmé, H., Kamler, M., Gulbins, E., & Wu, Y.
(2023). Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections. International Journal of Molecular Sciences, 24(18), 14004.
https://doi.org/10.3390/ijms241814004